In a troubling turn for Indian pharmaceutical giants, Glenmark, Sun Pharma, and Zydus are facing product recalls in the United States due to regulatory non-compliance and manufacturing deficiencies. The U.S. Food and Drug Administration (USFDA) flagged multiple deviations from Current Good Manufacturing Practices (CGMP), leading to recalls of widely prescribed medications for cardiac conditions, neurological disorders, and mental health issues. These enforcement actions highlight rising regulatory vigilance in the U.S.